Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
about
Systemic therapy in bladder cancerManagement of invasive bladder cancer in patients who are not candidates for or decline cystectomy.Single institutional experience of bladder-preserving trimodality treatment for muscle-invasive bladder cancer.Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells.
P2860
Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Concurrent platinum and doceta ...... f tolerance and local control.
@ast
Concurrent platinum and doceta ...... f tolerance and local control.
@en
type
label
Concurrent platinum and doceta ...... f tolerance and local control.
@ast
Concurrent platinum and doceta ...... f tolerance and local control.
@en
prefLabel
Concurrent platinum and doceta ...... f tolerance and local control.
@ast
Concurrent platinum and doceta ...... f tolerance and local control.
@en
P2093
P1433
P1476
Concurrent platinum and doceta ...... of tolerance and local control
@en
P2093
A Dimitrakopoulos
A Kranidis
D Haldeopoulos
E Mavromanolakis
G Daskalopoulos
G Metaxaris
H Varveris
J Damilakis
M Mazonakis
P304
P407
P577
1997-11-01T00:00:00Z